Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alumina column is a fundamental component of the Molybdenum-99/Technetium-99m generator system, widely used in nuclear medicine to produce the diagnostic radioisotope Technetium-99m (StatPearls, 2023). It consists of acidic aluminum oxide (Al2O3) which serves as a chromatographic stationary phase (Wikipedia, 2024). Molybdenum-99, the parent isotope, is loaded onto the column as molybdate ions, which bind tightly to the alumina (National Academies Press, 2009). As Molybdenum-99 decays, it produces Technetium-99m in the form of pertechnetate ions. Because pertechnetate has a significantly lower affinity for the alumina than molybdate, it can be selectively eluted with a sterile saline solution for use in patient imaging (Learn Radiology Physics, 2024). This system is not a biological target but a chemical substrate for isotope separation; however, monitoring for 'aluminum breakthrough' is essential to prevent chemical impurities from interfering with subsequent radiopharmaceutical labeling or patient safety (StatPearls, 2023). The column typically contains 5 to 10 grams of acid-washed alumina to ensure efficient adsorption and elution (StatPearls, 2023). It is designed to maintain sterile and pyrogen-free conditions for the production of injectable radiopharmaceuticals (AuntMinnie, 2002).
The alumina column serves as a stationary phase for the chromatographic separation of radionuclides. Molybdenum-99 (as molybdate) is strongly adsorbed onto the acidic alumina, while its decay product, Technetium-99m (as pertechnetate), has a lower affinity and is eluted using a sterile saline solution.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aluminum oxide (Al2O3).